CAL
LABU icon

Capital Analysts LLC’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Capital Analysts LLC’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25
Closed -$39K – 1024
2021
Q1 		$39K Buy
+25
New +$58.6K ﹤0.01% 618

Other funds holding LABU

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UMC
United Maritime Capital New York $15.2M AUM 45.42% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Analysts LLC's LABU Position: Q2 2021 in Review

Capital Analysts LLC sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2021, closing a stake of 25 shares — an estimated $39K sold.

Capital Analysts LLC first reported a position in LABU in Q1 2021 and held it in 1 quarter. The position peaked at $39K in Q1 2021. 24 funds tracked by Wall St. Rank hold LABU as of Q2 2021.

  • Capital Analysts LLC reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2021 after selling out during the quarter.
  • Capital Analysts LLC sold 25 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2021, an estimated $39K.
  • Capital Analysts LLC first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2021 and held it in 1 quarter.
  • Capital Analysts LLC's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $39K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2021.

Based on Capital Analysts LLC's 13F filing for Q2 2021, filed 5 Aug 2021.